Kyntra Bio, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
KYNB Nasdaq 2830 www.kyntrabio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Kyntra Bio, Inc.

Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes - Jun 11th, 2026 2:05 pm
Kyntra Bio Inc (KYNB) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic Advances ... - May 12th, 2026 1:07 am
Kyntra Bio (KYNB) Q1 2026 Earnings Transcript - May 11th, 2026 4:10 pm
Kyntra Bio (KYNB) Reports Q1 Loss, Tops Revenue Estimates - May 11th, 2026 4:05 pm
Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update - May 11th, 2026 2:05 pm
Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Beats Revenue Estimates - May 7th, 2026 6:50 am
Kyntra Bio to Report First Quarter 2026 Financial Results - May 4th, 2026 2:05 pm
Replays from RedChip's Biotech Investor Conference Now Available - Apr 20th, 2026 9:00 am
Kyntra Bio (KYNB) Upgraded to Buy: Here's What You Should Know - Apr 14th, 2026 10:00 am
RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation - Apr 10th, 2026 10:55 am
Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference - Apr 8th, 2026 2:05 pm
Kyntra Bio Inc (KYNB) Q4 2025 Earnings Call Highlights: Navigating Revenue Decline with ... - Mar 16th, 2026 9:00 pm
Kyntra Bio (KYNB) Q4 2025 Earnings Call Transcript - Mar 16th, 2026 4:08 pm
Kyntra Bio: Q4 Earnings Snapshot - Mar 16th, 2026 2:20 pm
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Mar 16th, 2026 2:02 pm
Monte Rosa Therapeutics (GLUE) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Mar 12th, 2026 8:00 am
Septerna, Inc. (SEPN) Reports Q4 Loss, Tops Revenue Estimates - Mar 9th, 2026 3:20 pm
Kyntra Bio (KYNB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Mar 9th, 2026 8:00 am
Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results - Mar 9th, 2026 5:00 am
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026 - Feb 23rd, 2026 3:10 pm